The main treatments offered at IRCA focus on malignant and benign brain tumours, neurovascular diseases and also functional diseases.
As mentioned above, the ZAP-X is the ZAP-X system, the ZAP-X is the most advanced stereotactic brain radiosurgery system in the sector, with cutting-edge technological innovation. And as mentioned above, it can be used to treat different pathologies, providing highly relevant data to support medical outcomes and efficiency.
Thanks to the ZAP-X, IRCA is able to offer treatments that are specially personalised for each patient, thinking not only of their recovery but also of their wellbeing throughout the process.
Treatments
Benign brain tumours
Within benign brain tumors, ZAP-X can treat acoustic neurinoma/ Vestibular Schwannoma, meningioma and pituitary adenoma. With well-differentiated, non-cancerous borders, these types of tumours are generally not very encysted in the brain tissue and are therefore easier to treat and remove.
Schwannoma
Pituitary adenomas
Meningioma
This tumour arises from the layers of the meninges, which is the protective membrane around the brain and spinal cord. Because of its location it is not considered a tumour, but is included in this category as it can compress the brain and/or nerves. It is the most common benign type, accounting for more than 30% of cases, and is thought to be related to genetic alterations. It is categorised into grades: (I) the tumour grows slowly; (II) it has an intermediate behaviour, therefore it can reappear once it is removed; and (III) it is considered aggressive, with very rapid growth.
In this case, the symptoms are related to several senses, not only the ear. Depending on where in the brain the tumour is located, signs can range from blurred vision to loss of smell; seizures, slurred speech or limb weakness are also possible.